Damanhour teaching hospital
Damanhūr, Damanhour, Egypt
NCT Number: NCT06570564
Sixty patients with intermittent claudication and type 2 diabetes mellitus. Their age will ranged from 45-55 years old. They recruited from internal department at Damanhour Medical National Institute (DMNI), Damanhour, Beheira Governorate, Egypt. Patients randomly assigned into three equal groups:
Group (A):
Upper limb exercises group consist of 20 patients. They received arm cranking exercise three times per week for three consecutive months plus routine physiotherapy program.
Group (B):
Lower limb exercises group consist of 20 patients. They received bicycling exercise three times per week for three consecutive months plus routine physiotherapy program.
Group (C):
The control group consisted of 20 patients. They received only routine physiotherapy program.
Looking for future studies?
Notify Me45 year–55 year
All sexes
Interventional
Not applicable
Damanhūr, Damanhour, Egypt
Sixty patients with intermittent claudication and type 2 diabetes mellitus. Their age ranged from 45-55 years old. They recruited from internal department at Damanhour Medical National Institute (DMNI), Damanhour, Beheira Governorate, Egypt. Patients randomly assigned into three equal groups:
Group (A):
Upper limb exercises group consist of 20 patients. They received arm cranking exercise three times per week for three consecutive months plus routine physiotherapy program.
Group (B):
Lower limb exercises group consist of 20 patients. They received bicycling exercise three times per week for three consecutive months plus routine physiotherapy program.
Group (C):
The control group consisted of 20 patients. They received only routine physiotherapy program.
Measurement equipment:
All patients were tested Maximum walking distance and Pain free walking distance by walking in the treadmill.
Therapeutic equipment:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Before starting the program, patients will perform an adaptation session for familiarization with the ergometer and also to identify the training load. For this, patients will perform 10 bouts of two minutes of exercising with a minimum load and two minute passive intervals between bouts. Patients will be instructed to maintain 50 revolutions per minute (RPM) during the exercise. Subsequently, to determine the training load for each session, patients will perform a progressive test where the load will be increased by 10 watts every minute of the test, following the protocol of two minutes of exercise with two minutes of interval
bicycle ergometer program will consist of a bicycling exercise 3 days per week. Exercise intensity was set at 70% of maximal load with 30 minutes per session. The exercise protocol also incorporated warm-up and cool-down sessions that involved stretches of the major lower limb muscle groups (total exercise time, 40-60 minutes)
Supervised treadmill exercise as routine physiotherapy program
Time frame: three consecutive months
the distance that had been walked on the treadmill when patients were unable to continue because of severe claudication pain
Time frame: three consecutive months
the distance that patients can walk on the treadmill before claudication pain begins
Time frame: three consecutive months
Claudication pain scale is a continuous scale from 1, indicating no pain, to 5 indicating severe pain
Time frame: three consecutive months
Time frame: three consecutive months
It is the average of blood glucose (sugar) levels for the last two to three months. If you have diabetes, an ideal HbA1c level is 48mmol/mol (6.5%) or below
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05232474
Arterial Occlusive Diseases, Arteriosclerosis
Nijmegen, Netherlands
View Trial DetailsNCT03204825
Agnosia, Arterial Occlusive Diseases
Glasgow, Strathcylde, United Kingdom
View Trial DetailsNCT03784729
Bone Diseases, Cardiovascular Diseases
Beijing, China
View Trial DetailsNCT05335161
Arterial Occlusive Diseases, Arteriosclerosis
West Lafayette, Indiana, United States
View Trial Details